1
|
Zang T, Cuttle L, Broszczak DA, Broadbent JA, Tanzer C, Parker TJ. Characterization of the Blister Fluid Proteome for Pediatric Burn Classification. J Proteome Res 2019; 18:69-85. [PMID: 30520305 DOI: 10.1021/acs.jproteome.8b00355] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
Blister fluid (BF) is a novel and viable research matrix for burn injury study, which can reflect both systemic and local microenvironmental responses. The protein abundance in BF from different burn severities were initially observed using a 2D SDS-PAGE approach. Subsequently, a quantitative data independent acquisition (DIA) method, SWATH, was employed to characterize the proteome of pediatric burn blister fluid. More than 600 proteins were quantitatively profiled in 87 BF samples from different pediatric burn patients. These data were correlated with clinically assessed burn depth and time until complete wound re-epithelialization through several different statistical analyses. Several proteins from these analyses exhibited significant abundance change between different burn depth or re-epithelialization groups, and can be considered as potential biomarker candidates. Further gene ontology (GO) enrichment analysis of the significant proteins revealed the most significant burn related biological processes (BP) that are altered with burn depth, including homeostasis and oxygen transport. However, for wounds with re-epithelialization times more or less than 21 days, the significant GO annotations were related to enzyme activity. This quantitative proteomics investigation of burn BF may enable objective classification of burn wound severity and assist with clinical decision-making. Data are available via ProteomeXchange with identifier PXD011102.
Collapse
Affiliation(s)
- Tuo Zang
- Tissue Repair and Translational Physiology Program , Institute of Health and Biomedical Innovation, Queensland University of Technology , Kelvin Grove , Queensland 4059 , Australia.,School of Biomedical Sciences, Faculty of Health , Queensland University of Technology , Brisbane , Queensland 4000 , Australia.,Wound Management Innovation Co-operative Research Centre , Brisbane , Queensland 4000 , Australia
| | - Leila Cuttle
- Tissue Repair and Translational Physiology Program , Institute of Health and Biomedical Innovation, Queensland University of Technology , Kelvin Grove , Queensland 4059 , Australia.,School of Biomedical Sciences, Faculty of Health , Queensland University of Technology , Brisbane , Queensland 4000 , Australia.,Centre for Children's Burns and Trauma Research, Queensland University of Technology , Institute of Health and Biomedical Innovation at the Centre for Children's Health Research , South Brisbane , Queensland 4101 , Australia
| | - Daniel A Broszczak
- Tissue Repair and Translational Physiology Program , Institute of Health and Biomedical Innovation, Queensland University of Technology , Kelvin Grove , Queensland 4059 , Australia.,School of Biomedical Sciences, Faculty of Health , Queensland University of Technology , Brisbane , Queensland 4000 , Australia.,School of Science, Faculty of Health Sciences , Australian Catholic University , Brisbane , Queensland 4014 , Australia
| | - James A Broadbent
- Tissue Repair and Translational Physiology Program , Institute of Health and Biomedical Innovation, Queensland University of Technology , Kelvin Grove , Queensland 4059 , Australia.,School of Biomedical Sciences, Faculty of Health , Queensland University of Technology , Brisbane , Queensland 4000 , Australia
| | - Catherine Tanzer
- Tissue Repair and Translational Physiology Program , Institute of Health and Biomedical Innovation, Queensland University of Technology , Kelvin Grove , Queensland 4059 , Australia.,Wound Management Innovation Co-operative Research Centre , Brisbane , Queensland 4000 , Australia.,Centre for Children's Burns and Trauma Research, Queensland University of Technology , Institute of Health and Biomedical Innovation at the Centre for Children's Health Research , South Brisbane , Queensland 4101 , Australia
| | - Tony J Parker
- Tissue Repair and Translational Physiology Program , Institute of Health and Biomedical Innovation, Queensland University of Technology , Kelvin Grove , Queensland 4059 , Australia.,School of Biomedical Sciences, Faculty of Health , Queensland University of Technology , Brisbane , Queensland 4000 , Australia
| |
Collapse
|
2
|
Abstract
OBJECTIVES To provide a detailed, sequential analysis of insulin-like growth factor-1 and its binding proteins in adults during the acute phase after a major burn injury. DESIGN Descriptive, repeated measurements for quantitation and characterization of insulin-like growth factor-1 and its binding proteins in adult burn survivors. SETTING Burn center in a university hospital. PATIENTS A total of 17 severely burned (>15% total body-surface area burned) adult patients. INTERVENTIONS Venous blood was collected twice a day for 10 days and centrifuged, and the sera were stored at -80 degrees C until analysis. A series of 340 serum samples were analyzed by radioimmunoassay to determine the circulating concentration of insulin-like growth factor-1 and its major binding proteins (insulin-like growth factor-binding protein), by Western ligand blotting. To better understand the changes seen in systemic insulin-like growth factor-binding protein-3 levels by Western ligand blotting, a proteolysis assay was performed. MEASUREMENTS AND MAIN RESULTS Insulin-like growth factor-1 levels were reduced from day 0 and correlated with insulin-like growth factor-binding protein-1 and -2 (p <.01), but not insulin-like growth factor-binding protein-3 and -4. Insulin-like growth factor-binding protein-3 was decreased relative to normal on day 0, declined further until day 3, and began recovering by day 6, but returned to only 35% of normal by day 10. Insulin-like growth factor-binding protein-1 and -2 were increased relative to normal and remained increased throughout the 10-day period. Insulin-like growth factor-binding protein-4 concentrations, however, were similar to normal at day 1 but gradually increased over time. Burn serum incubated with recombinant human glycosylated iodine-125 insulin-like growth factor-binding protein-3 did not demonstrate any proteolysis, although proteolysis of nonglycosylated iodine-125 insulin-like growth factor-binding protein-3 reached levels of approximately 40%. CONCLUSIONS Insulin-like growth factor-binding protein-3 proteolysis does not seem to be the mechanism by which systemic insulin-like growth factor-1 levels are reduced in major burn survivors. In vitro proteolysis of recombinant human glycosylated and nonglycosylated iodine-125 insulin-like growth factor-binding protein-3 does not reflect the in vivo situation in major burn survivors.
Collapse
|